A.G. Schneiderman Announces $54 Million Multistate Settlement With Astrazeneca LP And Cephalon, Inc. to Resolve Allegations of Overcharging Medicaid for Drugs
NEW YORK - Attorney General Eric T. Schneiderman today announced that New York has joined with all other states and the federal government to settle allegations with AstraZeneca LP and 48 other states, District of Columbia and the federal government with Cephalon that the companies overcharged state Medicaid programs for their pharmaceutical products. AstraZeneca, a Delaware limited partnership with its principal place of business in Delaware, and Cephalon, Inc. a Pennsylvania-based subsidiary of Teva Pharmaceutical Industries. Ltd., will pay the states and the federal government $54 million, of which Astra Zeneca LP will pay $46.5 million and Cephalon, $7.5 million. $7,493,604.39 will go to the New York State Medicaid Program based on the Astra Zeneca agreement and $996,110.12 will go to the New York State Medicaid Program based on the Cephalon, Inc. agreement.
- Date:November 4, 2015
- Agency:New York Attorney General
- State Enforcement Agencies